Literature DB >> 18166776

Hemolysis-associated hypercoagulability in sickle cell disease: the plot (and blood) thickens!

Mark T Gladwin, Gregory J Kato.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18166776      PMCID： PMC4263346          DOI： 10.3324/haematol.12318

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  63 in total

1.  Acute priapism in a patient with unstable hemoglobin Perth and Factor V Leiden under effective oral anticoagulant therapy.

Authors:  E Gyan; S Darre; B Jude; N Cambier; J L Demory; F Bauters; C Rose
Journal:  Hematol J       Date:  2001

2.  Delayed pulmonary hypertension following splenectomy for congenital spherocytosis.

Authors:  D L Jardine; A D Laing
Journal:  Intern Med J       Date:  2004-04       Impact factor: 2.048

3.  Successful pulmonary thromboendarterectomy in two patients with sickle cell disease.

Authors:  G L Yung; R N Channick; P F Fedullo; W R Auger; K M Kerr; S W Jamieson; D P Kapelanski; K M Moser
Journal:  Am J Respir Crit Care Med       Date:  1998-05       Impact factor: 21.405

4.  Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease.

Authors:  N S Key; A Slungaard; L Dandelet; S C Nelson; C Moertel; L A Styles; F A Kuypers; R R Bach
Journal:  Blood       Date:  1998-06-01       Impact factor: 22.113

5.  Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease.

Authors:  Christopher D Reiter; Xunde Wang; Jose E Tanus-Santos; Neil Hogg; Richard O Cannon; Alan N Schechter; Mark T Gladwin
Journal:  Nat Med       Date:  2002-11-11       Impact factor: 53.440

6.  Association of single nucleotide polymorphisms in klotho with priapism in sickle cell anaemia.

Authors:  Vikki G Nolan; Clinton Baldwin; Qianli Ma; Diego F Wyszynski; Yvonne Amirault; John J Farrell; Alice Bisbee; Stephen H Embury; Lindsay A Farrer; Martin H Steinberg
Journal:  Br J Haematol       Date:  2005-01       Impact factor: 6.998

7.  Hemolysis-associated priapism in sickle cell disease.

Authors:  Vikki G Nolan; Diego F Wyszynski; Lindsay A Farrer; Martin H Steinberg
Journal:  Blood       Date:  2005-06-28       Impact factor: 22.113

Review 8.  Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes.

Authors:  Gregory J Kato; Mark T Gladwin; Martin H Steinberg
Journal:  Blood Rev       Date:  2006-11-07       Impact factor: 8.250

9.  Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension.

Authors:  Kenneth I Ataga; Charity G Moore; Cheryl A Hillery; Susan Jones; Herbert C Whinna; Dell Strayhorn; Cathy Sohier; Alan Hinderliter; Leslie V Parise; Eugene P Orringer
Journal:  Haematologica       Date:  2008-01       Impact factor: 9.941

Review 10.  Hypercoagulability in sickle cell disease: a curious paradox.

Authors:  Kenneth I Ataga; Eugene P Orringer
Journal:  Am J Med       Date:  2003-12-15       Impact factor: 4.965
View more
  10 in total

1.  Mechanisms of hemolysis-associated platelet activation.

Authors:  C C Helms; M Marvel; W Zhao; M Stahle; R Vest; G J Kato; J S Lee; G Christ; M T Gladwin; R R Hantgan; D B Kim-Shapiro
Journal:  J Thromb Haemost       Date:  2013-12       Impact factor: 5.824

2.  A pilot study of subcutaneous decitabine in β-thalassemia intermedia.

Authors:  Nancy F Olivieri; Yogen Saunthararajah; Vivek Thayalasuthan; Janet Kwiatkowski; Russell E Ware; Frans A Kuypers; Hae-Young Kim; Felicia L Trachtenberg; Elliott P Vichinsky
Journal:  Blood       Date:  2011-06-23       Impact factor: 22.113

3.  Clinical characteristics and management of iron overload in 631 patients with chronic transfusion dependency: results from a multicentre, observational study.

Authors:  Joan Cid; Luis Palomera; Matías Díaz; Concha Zamora; Fernando Solano
Journal:  Blood Transfus       Date:  2013-03-14       Impact factor: 3.443

4.  Neither a nitric oxide donor nor potassium channel blockage inhibit RBC mechanical damage induced by a roller pump.

Authors:  Pinar Ulker; Herbert J Meiselman; Oguz K Baskurt
Journal:  Open Biomed Eng J       Date:  2008-04-01

Review 5.  Coagulation abnormalities of sickle cell disease: Relationship with clinical outcomes and the effect of disease modifying therapies.

Authors:  Denis Noubouossie; Nigel S Key; Kenneth I Ataga
Journal:  Blood Rev       Date:  2015-12-24       Impact factor: 8.250

6.  Vasculo-toxic and pro-inflammatory action of unbound haemoglobin, haem and iron in transfusion-dependent patients with haemolytic anaemias.

Authors:  Francesca Vinchi; Richard Sparla; Sara T Passos; Richa Sharma; S Zebulon Vance; Hala S Zreid; Hesham Juaidi; Deepa Manwani; Karina Yazdanbakhsh; Vijay Nandi; André M N Silva; Anand R Agarvas; Eitan Fibach; John D Belcher; Gregory M Vercellotti; Husam Ghoti; Martina U Muckenthaler
Journal:  Br J Haematol       Date:  2021-03-15       Impact factor: 6.998

Review 7.  Sickle cell disease: new opportunities and challenges in Africa.

Authors:  J Makani; S F Ofori-Acquah; O Nnodu; A Wonkam; K Ohene-Frempong
Journal:  ScientificWorldJournal       Date:  2013-09-19

Review 8.  Linking Labile Heme with Thrombosis.

Authors:  Marie-Thérèse Hopp; Diana Imhof
Journal:  J Clin Med       Date:  2021-01-22       Impact factor: 4.241

9.  Examination of Reticulocytosis among Chronically Transfused Children with Sickle Cell Anemia.

Authors:  Megha Kaushal; Colleen Byrnes; Zarir Khademian; Natalie Duncan; Naomi L C Luban; Jeffery L Miller; Ross M Fasano; Emily Riehm Meier
Journal:  PLoS One       Date:  2016-04-26       Impact factor: 3.240

10.  Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: A randomized phase 1 study.

Authors:  Robert Molokie; Donald Lavelle; Michel Gowhari; Michael Pacini; Lani Krauz; Johara Hassan; Vinzon Ibanez; Maria A Ruiz; Kwok Peng Ng; Philip Woost; Tomas Radivoyevitch; Daisy Pacelli; Sherry Fada; Matthew Rump; Matthew Hsieh; John F Tisdale; James Jacobberger; Mitch Phelps; James Douglas Engel; Santhosh Saraf; Lewis L Hsu; Victor Gordeuk; Joseph DeSimone; Yogen Saunthararajah
Journal:  PLoS Med       Date:  2017-09-07       Impact factor: 11.069
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.